Clinical Trials
64 trialsStudy of Docetaxel or Vinorelbine Plus Cisplatin in Neoadjuvant Chemoradiotherapy for Esophageal Cancer (NEOCRTEC308)
Sun Yat-sen University
FOLFOX-6 Induction Chemotherapy Followed by Esophagectomy and Post-operative Chemoradiotherapy in Patients With Esophageal Adenocarcinoma
Case Comprehensive Cancer Center
Maintenance Ipilimumab + Nivolumab Post Induction Chemotherapy + SBRT for First Line Treatment Stage IV Pancreatic Cancer
Sheba Medical Center
Envafolimab Combined With Endostar and Concurrent Chemoradiotherapy for Locally Advanced Primary Cervical Cancer
Peking University Third Hospital
Pulsed Low Dose Rate Radiation With Concurrent Chemotherapy for Non-Small Cell Lung Cancer and Esophageal Cancer
Fox Chase Cancer Center
CONVERT: Neoadjuvant Chemotherapy Alone Versus Preoperative Chemoradiation for Locally Advanced Rectal Cancer Patients
Sun Yat-sen University
Toripalimab Plus Radiotherapy for Elderly Esophageal Cancer Patients Treated With Non-chemotherapy Strategy
Taizhou Hospital
DCIS
Trans Tasman Radiation Oncology Group
TBMPPF
Sun Yat-sen University
Chemo Alone or in Combination With Radiation in Unresectable Cholangiocarcinoma
Tata Memorial Hospital
FOLRT
Campus Bio-Medico University
Chemoradiotherapy Combined With or Without PD-1 Blockade in Anal Canal Squamous Carcinoma Patients
Sixth Affiliated Hospital, Sun Yat-sen University
Phase II Study of DC Versus 5-FU/CF as Chemotherapy and Concurrent Chemoradiotherapy for Locally Advanced Gastric Cancer
Wuhan University
Influence of Different Light Dose on the Adverse Effect of Swallowing for Esophageal Carcinoma
The First Affiliated Hospital of Henan University of Science and Technology
REVO
Fujian Cancer Hospital
Local Radiotherapy in Combination With Immunotherapy in Advanced Solid Tumors Patients
Ruijin Hospital
Carboplatin and Paclitaxel With or Without Cisplatin and Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IVA Endometrial Cancer
GOG Foundation
Study of Camrelizumab (SHR-1210) in Combination With Concurrent Chemoradiotherapy in Locally Advanced Esophageal Cancer
Jiangsu HengRui Medicine Co., Ltd.
The Effect of Alpha Lipoic Acid on the Incidence and Severity of Radiotherapy-Induced Oral Mucositis in Head and Neck Cancer Patients
Ain Shams University
Safety and Efficacy of Sintilimab in Combination With Chemoradiothrapy Followed by D2 Surgical Resection in Patients With Advanced Gastric Cancer With Retroperitoneal Lymph Node Metastasis
Ruijin Hospital
A Study to Evaluate the Safety of Concurrent Durvalumab With CRT Followed by Durvalumab for Chinese Unresectable Stage III NSCLC
Shandong Cancer Hospital and Institute
An Alternative Radiation Fractionation Strategy for Locally Advanced Non-Small Cell Lung Cancer (NSCLC)
Emory University
neoadjuvant_thymic Epithelial Tumor
Samsung Medical Center
Combination of Radiation Therapy and Anti-PD-1 Antibody in Treating Patients With Pancreatic Cancer
Hangzhou Cancer Hospital
Neoadjuvant PD-1 in Newly Diagnosed Glioblastoma
Peking Union Medical College Hospital
PAraDiGM
Centre Leon Berard
Combination of Hyperthermia and Concurrent Chemoradiotherapy (CCRT) for Recurrent Head and Neck Cancer
Shin Kong Wu Ho-Su Memorial Hospital
Real-world Treatment Patterns and Clinical Outcomes in EGFR-mutant Unresectable Locally Advanced NSCLC
ChineseAMS
Study on Predictive Biomarkers of Neoadjuvant Chemoradiotherapy for Rectal Cancer
Fudan University
Radical Radiotherapy and Chemotherapy Combined With Maintenance Chemotherapy in the Treatment of Stage N3 NPC
Fujian Cancer Hospital
Hypofractionated Accelerated Radiotherapy With Concomitant Chemotherapy for NSCLC
Independent Public Care Health Facility of the Ministry of the Interior and Warmian & Mazurian Oncology Centre
A Study of Sintilimab Plus Chemoradiation Before Surgery for Esophageal Cancer
Zhejiang Cancer Hospital
InSituVac1
Beijing Tiantan Hospital
A Randomized Study of Primary Tumor Radiotherapy for Patients With MPE Stage IV NSCLC
Guizhou Medical University
Adoptive Cell Therapy Following a Reduced Intensity, Non-myeloablative, Lymphodepleting Induction Regimen in Metastatic Ovarian
Sheba Medical Center
Neoadjuvant CCRT With/Without Bevacizumab for Locally Advanced ESCC
National Taiwan University Hospital
Radiation-protection Effect of Amifostine in Locally Advanced Rectal Cancer
Fudan University
Effect of Radiation and Its Timing on Breast Reconstruction in Chinese Patients
Tianjin Medical University Cancer Institute and Hospital
A Study of OBP-301 With Radiation Therapy in Patients With Esophageal Cancer
Oncolys BioPharma Inc
Nimotuzumab for Recurrent Nasopharyngeal Carcinoma
Fujian Cancer Hospital
Involved Field Radiotherapy for Non-gastric Marginal Zone Lymphoma
Trans Tasman Radiation Oncology Group
Adjuvant Radiotherapy for Esophageal Squamous Cell Carcinoma With Positive Circumstantial Resection Margin
Fudan University
Phase II Study of Extensive Clinical Target Volumes in Postoperative Radiotherapy for Esophageal Squamous Cell Carcinoma
Fudan University
HYCAN
University of Erlangen-Nürnberg Medical School
Neoadjuvant Concurrent Chemoradiation With Weekly Docetaxel/Cisplatin for Resectable IIIA-N2 NSCLC
Peking University People's Hospital
Radiation Therapy and Combination Chemotherapy for Medulloblastoma
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Adjuvant Gemcitabine Versus Gemcitabine With Chemoradiation in Pancreatic Adenocarcinoma With R1 Resection and/or Positive Lymph Nodes
Peking Union Medical College Hospital
Concurrent Chemoradiotherapy(CRT) in Locally Advanced(LA) SCCHN vs Cetuximab With Radiotherapy (RT) After Neoadjuvant Chemotherapy
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Adjuvant Chemotherapy With Paclitaxel and Cisplatin in Lymph Node-Positive Adjuvant Chemotherapy in the Treatment of the Lymph Node Positive Thoracic Esophageal Squamous Cell Carcinoma
ChineseAMS
Preoporative Bevacizumab, Radiation Therapy, and XELOX Chemotherapy for Locally Advanced Nonmetastatic Rectal Cancer
Sun Yat-sen University